Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationals for optimizing bladder cancer treatment and control.

H Wolf1

  • 1Division of Urology, Surgical Department I, Aarhus Amtssygehus, Denmark.

Scandinavian Journal of Urology and Nephrology. Supplementum
|January 1, 1989
PubMed
Summary

Bladder cancer survival remains limited due to tumor biology. Tumors possess inherent invasion potential, making treatment difficult. Non-invasive tumors are not fatal, unlike invasive bladder cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Oral hairy leukoplakia in human immunodeficiency virus positive patients: clinical and etiopathogenic aspects].

Acta otorrinolaringologica espanola·1992
Same author

Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.

AIDS research and human retroviruses·1992
Same author

Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.

European journal of immunology·1992
Same author

Localization and identification of T-(Gal beta 1-3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer.

The Journal of urology·1992
Same author

Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.

Cancer research·1992
Same author

Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer.

International journal of cancer·1992

Area of Science:

  • Uro-oncology
  • Cancer biology
  • Clinical oncology

Background:

  • Bladder cancer patient survival has seen limited improvement despite optimized treatment schedules.
  • Bladder tumors exhibit inherent biological potential for invasion that is difficult to modify with current therapies.

Purpose of the Study:

  • To investigate the biological factors influencing bladder cancer patient survival.
  • To understand the dichotomy between invasive and non-invasive bladder tumors regarding patient outcomes.

Main Methods:

  • Review of existing literature on bladder cancer treatment and patient survival.
  • Analysis of tumor characteristics, specifically invasive potential.
  • Correlation of tumor stage (non-invasive vs. invasive) with patient prognosis.

Main Results:

  • Bladder tumors appear to possess a fixed biological potential for invasion.
  • Non-invasive (Ta) bladder tumors do not typically lead to patient mortality.
  • Invasive bladder tumors are associated with localized disease or regional/distant metastases, significantly impacting survival.

Conclusions:

  • The inherent biological potential of bladder tumors is a critical determinant of patient survival.
  • Treatment strategies may be limited by the intrinsic invasive nature of bladder cancer.
  • Distinguishing between non-invasive and invasive bladder tumors is crucial for predicting patient outcomes.

Related Experiment Videos